Latest Flibanserin Stories

2014-02-11 08:31:56

Agency Proposes Select Phase I Studies as Part of Resubmission RALEIGH, N.C., Feb. 11, 2014 /PRNewswire/ -- Sprout Pharmaceuticals announced today that their Formal Dispute Resolution, which was filed in December 2013, resulted in clear guidance from the FDA on the path forward. Sprout will resubmit the New Drug Application (NDA) for flibanserin, a once-daily treatment for Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women, by the third quarter. The FDA has requested...

2011-01-06 09:10:00

SADDLE BROOK, N.J., Jan. 6, 2011 /PRNewswire/ -- The FDA's nod to a new testosterone gel for men will expand the options they have to address the problems of sexual dysfunction. "So where does this leave women?" asks Rachel Braun Scherl, president of Semprae Laboratories, Inc. The announcement of the approval of Fortesta comes just months after the FDA's unanimous rejection of Flibanserin. Dubbed the "pink pill," the female Viagra equivalent, many thought it would be the game changer in...

2010-10-09 07:40:00

"Pink Viagra," an experimental pill claiming to boost a woman's sex drive, has been scrapped by German maker Boehringer Ingelheim after failing to convince US regulators that the pill actually worked. "The decision was not made lightly, considering the advanced stage of development," CEO Andreas Barner told Reuters on Friday. The company had hoped the pill would have been a potential windfall aimed at premenopausal women with a persistent lack of sex drive. The move marked the failure of...

2010-10-01 13:59:27

Feature: Merging of marketing and medical science: female sexual dysfunction Drug companies have not only sponsored the science of a new condition known as female sexual dysfunction, they have helped to construct it, in order to build global markets for new drugs, reveals an article in this week's BMJ. Researching his new book 'Sex, Lies and Pharmaceuticals' Ray Moynihan, journalist and lecturer at the University of Newcastle in Australia, discovered that drug industry employees have worked...

2010-06-19 07:10:00

On Friday, a U.S. panel of experts debated to approve the first pill that helps boost a woman's sex drive, as its German manufacturer pressed for the drug to reach the lucrative market. Boehringer Ingelheim officials wanted to convince the U.S. Food and Drug Administration (FDA) that their little pink pill was harmless and effective. The FDA usually follows these panels' advice, even though it is not required to do so by law. Flibanserin is the latest effort to come up with a female...

2010-06-18 15:32:00

RIDGEFIELD, Conn., June 18 /PRNewswire/ -- The Reproductive Health Drugs Advisory Committee met today to discuss the new drug application (NDA) for flibanserin 100 mg as a treatment for Hypoactive Sexual Desire Disorder (HSDD) in pre-menopausal women. The advisory committee was convened by and makes recommendations to the U.S. Food and Drug Administration (FDA). The FDA will consider the committee's advice as part of its final assessment of the NDA. The committee recognized the...

2010-06-17 06:35:00

The drug industry's latest attempt to find a female equivalent to Viagra fell short in two separate studies, according to federal regulators on Wednesday. The Food and Drug Administration is considering Boehringer Ingelheim's drug flibanserin for pre-menopausal women who experienced a lack in sexual desire, a market that drug makers have been targeting for years since the epic success of Viagra for men. The hunt for a female version of Viagra has proved elusive though, with many drugs...

Word of the Day
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.